Hepatitis B surface antigen (HBsAg) prevalence in Mozambique
Mozambique: Hepatitis B surface antigen (HBsAg) prevalence was 1.1% in 2024. ▼ Falling
Latest (2024)
1.1%
Change on year
unchanged
World rank
26th
of 194 countries
All-time high
2.1%
in 2015
All-time low
0.9%
in 2021
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Mozambique, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Mozambique recorded 1.1% for hepatitis b surface antigen (hbsag) prevalence in 2024.
Compared with earlier readings it is down 47.6% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Mozambique peaked at 2.1% in 2015 and was at its lowest, 0.9%, in 2021.
Mozambique ranks 26th of 194 countries on this measure, in the top quarter.
Hepatitis B surface antigen (HBsAg) prevalence in Mozambique, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 2.1% | — |
| 2016 | 1.8% | -14.3% |
| 2017 | 1.5% | -16.7% |
| 2018 | 1.2% | -20.0% |
| 2019 | 1.0% | -16.7% |
| 2020 | 1.0% | +0.0% |
| 2021 | 0.9% | -10.0% |
| 2022 | 1.0% | +11.1% |
| 2023 | 1.1% | +10.0% |
| 2024 | 1.1% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.5% | 1.0% | 2.1% | 5 |
| 2020s | 1.0% | 0.9% | 1.1% | 5 |
Countries ranked near Mozambique
More health data for Mozambique
- Un projection of annual infant deaths, annual growth rate -1.85 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.16 % change on previous year (2090)
- Heat deaths vs projected death rates 869.7 (2090)
- Un projection of annual infant deaths 18,288 (2100)
- Population ages 15-64, male, annual growth rate 3.75 % change on previous year (2025)
- Population ages 15-64, male, per unit of GDP 0.0004 units per US$ of GDP (2025)
- Population ages 15-64, male, per capita 0.2549 units per person (2025)
- Population ages 15-64, total, annual growth rate 3.53 % change on previous year (2025)
- Population ages 15-64, total, per unit of GDP 0.0008 units per US$ of GDP (2025)
- Population ages 15-64, total, per capita 0.531 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Mozambique?
- Hepatitis b surface antigen (hbsag) prevalence in Mozambique was 1.1% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Mozambique?
- The highest recorded value was 2.1% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Mozambique?
- The lowest recorded value was 0.9% in 2021.
- How does Mozambique rank for hepatitis b surface antigen (hbsag) prevalence?
- Mozambique ranks 26th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Mozambique?
- Over the last ten years it is down 47.6%. The long-run trend across the full record is falling.
- Where does this Mozambique data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).